Drug Delivery Devices & Primary Pharmaceutical Packaging - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Drug Delivery Devices & Primary Pharmaceutical Packaging

Phillips-Medisize offers innovative manufacturing solutions for specialized healthcare products, including complex drug delivery devices as well as primary pharmaceutical packaging such as bottles, closures, dosing systems and flexible containers. Our strength is founded on a deep engineering expertise, supported by advanced manufacturing capabilities like high-speed automated assembly. An own product and design development department is capable to deliver the complete solution - from design to commercialization - for a fully assembled and packaged drug delivery device or primary pharmaceutical packaging.We develop bottles, dosing systems and closures to our customers’ designs and requirements. We can tailor a complete primary packaging system to your needs. Customised drug delivery devices developed and/or produced by us to customer specifications include injector pens, inhalers, syringes with safety devices, inserters and applicators.

Company name:  Phillips-Medisize

Website: www.phillipsmedisize.com

E-mail: eu_sales@phillipsmedisize.com
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
29%
Breakthrough designations
10%
Protecting the supply chain
43%
Expedited reviews of drug submissions
10%
More stakeholder involvement
10%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
FindPharma Custom Search

Click here